|
MechanismmAChRs antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.United States |
First Approval Date11 May 1950 |
100 Clinical Results associated with Aptalis Pharma US, Inc.
0 Patents (Medical) associated with Aptalis Pharma US, Inc.
100 Deals associated with Aptalis Pharma US, Inc.
100 Translational Medicine associated with Aptalis Pharma US, Inc.